Wednesday, 21 January 2015

Heart Failure Drugs Slow Deadly Damage in Duchenne, Offering New Hope - PPMD Community

Heart Failure Drugs Slow Deadly Damage in Duchenne, Offering New Hope - PPMD Community: "Less heart muscle damage was seen at 6 months, and less decline in heart function was seen at 12 months when adding eplerenone to background ACE inhibitor or ARB therapy compared to adding placebo. The research team believes that by benefiting heart function at a very early stage, longer-term complications of cardiomyopathy such as heart failure can be greatly reduced. While continued research is needed to develop even better treatments for tomorrow, the availability of these medicines offers boys with Duchenne something beneficial for their hearts today."



'via Blog this'

No comments:

Post a comment